118 related articles for article (PubMed ID: 2383856)
1. The role of calcium in differentiation of leukemic cell lines.
Rephaeli A; Aviram A; Rabizadeh E; Englender T; Shaklai M
Cancer Biochem Biophys; 1990 Apr; 11(2):119-25. PubMed ID: 2383856
[TBL] [Abstract][Full Text] [Related]
2. Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
Cancer Res; 1986 Dec; 46(12 Pt 1):6059-63. PubMed ID: 3465433
[TBL] [Abstract][Full Text] [Related]
3. Proliferation-associated changes of Ca2+ transport in myeloid leukemic cell lines.
Rephaeli A; Aviram A; Rabizadeh E; Shaklai M
J Cell Physiol; 1990 Apr; 143(1):154-9. PubMed ID: 2180964
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions between bile acids, all-trans retinoic acid, and 1,25-dihydroxy-vitamin D3 on monocytic differentiation and myeloblastin gene down-regulation in HL60 and THP-1 human leukemia cells.
Zimber A; Chedeville A; Abita JP; Barbu V; Gespach C
Cancer Res; 2000 Feb; 60(3):672-8. PubMed ID: 10676652
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
7. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
8. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
9. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
10. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells.
Chaplinski TJ; Bennett TE; Caro JF
Cancer Res; 1986 Mar; 46(3):1203-7. PubMed ID: 3002611
[TBL] [Abstract][Full Text] [Related]
11. Stimulatory effect of thyroid hormone on RA-induced granulocytic differentiation in leukemic cells.
Ballerini P; Lenoble M; Balitrand N; Schaison G; Najean Y; Chomienne C
Leukemia; 1991 May; 5(5):383-5. PubMed ID: 1851908
[TBL] [Abstract][Full Text] [Related]
12. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
Yen A; Sturgill R; Varvayanis S
Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.
Matsui T; Nakao Y; Koizumi T; Katakami Y; Fujita T
Cancer Res; 1986 Feb; 46(2):583-7. PubMed ID: 3606750
[TBL] [Abstract][Full Text] [Related]
14. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
Sokoloski JA; Shyam K; Sartorelli AC
Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
[TBL] [Abstract][Full Text] [Related]
15. Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Jpn J Cancer Res; 1987 Sep; 78(9):921-31. PubMed ID: 3117748
[TBL] [Abstract][Full Text] [Related]
16. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
Ghezzo F; Palumbo A; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
[TBL] [Abstract][Full Text] [Related]
17. Leukemic cell maturation: variability of the myeloid leukemic cell phenotype.
Ross DW; Pryzwansky KB; Prenant M; Dent G
Blood Cells; 1986; 12(1):139-51. PubMed ID: 3466656
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs.
Chomienne C; Chedeville A; Balitrand N; De Cremoux P; Abita JP; Degos L
In Vivo; 1988; 2(3-4):281-8. PubMed ID: 2979844
[TBL] [Abstract][Full Text] [Related]
19. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
20. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
Hemmi H; Breitman TR
Jpn J Cancer Res; 1985 May; 76(5):345-51. PubMed ID: 2989063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
